Center-Authored Papers

Filters: Author is Bensinger, W I  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Becker PS, Gooley TA, Green DJ, Burwick N, Kim TY, Kojouri K, Inoue Y, Moore DJ, Nelli E, Dennie T et al..  2016.  A phase 2 study of bortezomib, cyclophosphamide, pegylated liposomal doxorubicin and dexamethasone for newly diagnosed multiple myeloma.. Blood cancer journal. 6:e422.
Bensinger WI, Becker PS, Gooley TA, Chauncey TR, Maloney DG, Gopal AK, Green DJ, Press OW, Lill M, Ifthikharuddin JJ et al..  2016.  A randomized study of melphalan 200 mg/m(2) vs 280 mg/m(2) as a preparative regimen for patients with multiple myeloma undergoing auto-SCT.. Bone marrow transplantation. 51(1):67-71. Abstract
Brunvand MW, Bensinger WI, Soll E, Weaver CH, Rowley SD, Appelbaum FR, Lilleby K, Clift RA, Gooley TA, Press OW et al..  1996.  High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells.. Bone marrow transplantation. 18(1):131-41. Abstract
G
Gopal AK, Gooley TA, Golden JB, Maloney DG, Bensinger WI, Petersdorf SH, Appelbaum FR, Press OW.  2001.  Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older.. Bone marrow transplantation. 27(6):593-9. Abstract
Graf SA, Stevenson PA, Holmberg LA, Till BG, Press OW, Chauncey TR, Smith SD, Philip M, Orozco JJ, Shustov AR et al..  2015.  Maintenance rituximab after autologous stem cell transplantation in patients with mantle cell lymphoma.. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 26(11):2323-8. Abstract
Green DJ, Bensinger WI, Holmberg LA, Gooley T, Till BG, Budde LE, Pagel JM, Frayo SL, Roden JE, Hedin L et al..  2016.  Bendamustine, etoposide and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in patients with multiple myeloma.. Bone marrow transplantation. Abstract
Gutierrez-Delgado F, Maloney DG, Press OW, Golden J, Holmberg LA, Maziarz RT, Hooper H, Buckner CD, Appelbaum FR, Bensinger WI.  2001.  Autologous stem cell transplantation for non-Hodgkin's lymphoma: comparison of radiation-based and chemotherapy-only preparative regimens.. Bone marrow transplantation. 28(5):455-61. Abstract
K
Klippel ZK, Chou J, Towlerton AM, Voong LN, Robbins P, Bensinger WI, Warren EH.  2014.  Immune escape from NY-ESO-1-specific T-cell therapy via loss of heterozygosity in the MHC.. Gene therapy. 21(3):337-42. Abstract
M
Miller CP, Rattray K, Zhang Y, Wood BL, Burwick N, Chien S, Bensinger WI, Blau CA, Becker PS.  2012.  Evaluating surface erythropoietin receptor in multiple myeloma.. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 26(8):1883-6.
P
Pham RN, Gooley TA, Keeney GE, Press OW, Pagel JM, Greisman HA, Bensinger WI, Holmberg LA, Petersdorf SH, Maloney DG et al..  2007.  The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphoma.. Bone marrow transplantation. 40(11):1039-44. Abstract
Phipps C, Linenberger M, Holmberg LA, Green D, Becker P, Connelly-Smith L, Klippel Z, Burwick N, Gopal A, Bensinger WI et al..  2015.  Utilization of stored autologous PBSCs to support second autologous transplantation in multiple myeloma patients in the era of novel agent therapy.. Bone marrow transplantation. 50(5):663-7. Abstract